Joyce Kamwana, an ambassador with the Here I Am campaign and a great friend to ONE, visited our office in D.C. a few weeks ago. Joyce, who has been living with HIV for more than two decades, shares her inspiring story with us in this exclusive ONE interview.
Great news — more than 5.25 million people are currently receiving life-saving antiretroviral therapy (ART) for AIDS in low-and middle-income countries, says a report released this morning by UNAIDS, WHO and UNICEF.
This represents an impressive 30 percent increase in treatment coverage from just one year earlier. Sub-Saharan Africa had the greatest increase in the number of people receiving treatment — from 2.95 million in 2008 to 3.91 million in 2009.
From online petitions to angry baby protests, it’s hard to miss ONE’s focus on the Global Fund and our goal to ensure that virtually no child is born with HIV by 2015. But throughout this campaign, many of you have rightfully asked, “How does this exactly work?”
At the big International AIDS Conference in Vienna a few weeks back, there was wide coverage of positive trial results for a new microbicide –- a gel that women can use to reduce their risk of getting infected with HIV.
Giving women a prevention tool that they can use to protect themselves from the virus is critical. Right now, they have to depend on men to use condoms or other methods — and you can see how well that’s going.